uk 68798 has been researched along with nifekalant hydrochloride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mitamura, H; Ogawa, S; Okada, Y; Sadanaga, T | 1 |
Chen, J; Hashimoto, K; Komori, S; Li, B; Tamura, K | 1 |
Chen, IS; Furutani, K; Handa, K; Kurachi, Y; Sack, JT; Tsumoto, K; Yamakawa, Y | 1 |
1 trial(s) available for uk 68798 and nifekalant hydrochloride
Article | Year |
---|---|
Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography.
Topics: Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Female; Humans; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Piperidines; Pyridines; Pyrimidinones; Regression Analysis; Sotalol; Statistics, Nonparametric; Sulfonamides | 1996 |
2 other study(ies) available for uk 68798 and nifekalant hydrochloride
Article | Year |
---|---|
IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Vessels; Heart Rate; Ischemia; Male; Phenethylamines; Procainamide; Pyrimidinones; Rats; Rats, Sprague-Dawley; Reperfusion; Sulfonamides | 1996 |
Facilitation of
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cells, Cultured; ERG1 Potassium Channel; HEK293 Cells; Humans; Myocytes, Cardiac; Phenethylamines; Potassium Channel Blockers; Pyrimidinones; Rabbits; Sulfonamides; Xenopus | 2019 |